This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top 5 Small-Cap Stocks

NEW YORK ( TheStreet) -- The five small-cap stocks rated highest by TheStreet Ratings have all increased earnings over the past year, and three have double-digit upside based on price targets.

The following five companies have market capitalizations of between$50 million and $500 million and are rated at least B+, which is equivalent to a "buy":

5. Atrion Corp.

Company Profile

Atrion Corp. (ATRI) of Allen, Texas, was founded in 1944 and manufactures medical and fluid delivery devices. The shares closed at $151.50 Tuesday, down 2% year-to-date.

Income Statement

The company reported second-quarter net income of $5.43 million, or $2.67 a share, increasing from $4.70 million, or $2.31 a share, the previous quarter and $4.66 million, or 2.30 a share, a year earlier. Second-quarter revenue was $27.9 million, increasing 7% year-over-year, with CEO Emile Battat saying that sales in the "Marine and Airline markets increased sharply in this year's second quarter."

Balance Sheet

Atrion's quick ratio is 2.41, showing a strong ability to cover short-term cash needs. The company has no long-term debt.

Stock Ratios

Shares trade for 16 times earnings, lower than some of the small-cap companies in the Health Care Equipment and Supplies category, including ICU Medical (ICUI - Get Report) whose shares trade for 21 times earnings and Merit Medical Systems (MMSI - Get Report), which has a P/E of 22..

Analyst Ratings

According to Thomson Reuters, there are no sell-side analysts covering Atrion Corp. TheStreet Ratings rates the shares a B+ (Buy), and has a 12-month price target of $173.06, implying 14% upside.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CPK $48.98 -2.60%
HWKN $41.00 -1.40%
ICUI $87.05 -1.40%
MMSI $20.98 1.90%
ODC $33.61 -0.27%

Markets

DOW 18,081.67 +1.53 0.01%
S&P 500 2,111.82 -5.87 -0.28%
NASDAQ 5,065.54 -26.5450 -0.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs